A citation-based method for searching scientific literature

L Monnier, C Colette, D Owens. Diabetes Metab 2018
Times Cited: 6







List of co-cited articles
33 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients.
Antonio Ceriello, Katherine Esposito, Ludovica Piconi, Michael A Ihnat, Jessica E Thorpe, Roberto Testa, Massimo Boemi, Dario Giugliano. Diabetes 2008
679
66

Toward Defining the Threshold Between Low and High Glucose Variability in Diabetes.
Louis Monnier, Claude Colette, Anne Wojtusciszyn, Sylvie Dejager, Eric Renard, Nicolas Molinari, David R Owens. Diabetes Care 2017
120
66

Mean amplitude of glycemic excursions, a measure of diabetic instability.
F J Service, G D Molnar, J W Rosevear, E Ackerman, L C Gatewood, W F Taylor. Diabetes 1970
817
66


Effects of intensive glucose lowering in type 2 diabetes.
Hertzel C Gerstein, Michael E Miller, Robert P Byington, David C Goff, J Thomas Bigger, John B Buse, William C Cushman, Saul Genuth, Faramarz Ismail-Beigi, Richard H Grimm,[...]. N Engl J Med 2008
50

Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes.
Louis Monnier, Emilie Mas, Christine Ginet, Françoise Michel, Laetitia Villon, Jean-Paul Cristol, Claude Colette. JAMA 2006
50

International Consensus on Use of Continuous Glucose Monitoring.
Thomas Danne, Revital Nimri, Tadej Battelino, Richard M Bergenstal, Kelly L Close, J Hans DeVries, Satish Garg, Lutz Heinemann, Irl Hirsch, Stephanie A Amiel,[...]. Diabetes Care 2017
560
50

The application of simple metrics in the assessment of glycaemic variability.
L Monnier, C Colette, D R Owens. Diabetes Metab 2018
35
50

Insulin as an anti-inflammatory and antiatherogenic modulator.
Paresh Dandona, Ajay Chaudhuri, Husam Ghanim, Priya Mohanty. J Am Coll Cardiol 2009
109
33

Regulation of oxidative stress by glycaemic control: evidence for an independent inhibitory effect of insulin therapy.
L Monnier, C Colette, E Mas, F Michel, J P Cristol, C Boegner, D R Owens. Diabetologia 2010
100
33

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Steven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann, Michael A Nauck, Steven E Nissen, Stuart Pocock, Neil R Poulter, Lasse S Ravn,[...]. N Engl J Med 2016
33

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Steven P Marso, Stephen C Bain, Agostino Consoli, Freddy G Eliaschewitz, Esteban Jódar, Lawrence A Leiter, Ildiko Lingvay, Julio Rosenstock, Jochen Seufert, Mark L Warren,[...]. N Engl J Med 2016
33

Effects of prandial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: the HEART2D trial.
Itamar Raz, Peter W F Wilson, Krzysztof Strojek, Irina Kowalska, Velimir Bozikov, Anselm K Gitt, György Jermendy, Barbara N Campaigne, Lisa Kerr, Zvonko Milicevic,[...]. Diabetes Care 2009
229
33



Glucagon-like peptide 1 receptor agonist or bolus insulin with optimized basal insulin in type 2 diabetes.
Michaela Diamant, Michael A Nauck, Rimma Shaginian, James K Malone, Simon Cleall, Matthew Reaney, Danielle de Vries, Byron J Hoogwerf, Leigh MacConell, Bruce H R Wolffenbuttel. Diabetes Care 2014
146
33




DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality.
Thomas R Pieber, Steven P Marso, Darren K McGuire, Bernard Zinman, Neil R Poulter, Scott S Emerson, Richard E Pratley, Vincent Woo, Simon Heller, Martin Lange,[...]. Diabetologia 2018
68
33


Long-term Glycemic Variability and Risk of Adverse Outcomes: A Systematic Review and Meta-analysis.
Catherine Gorst, Chun Shing Kwok, Saadia Aslam, Iain Buchan, Evangelos Kontopantelis, Phyo K Myint, Grant Heatlie, Yoon Loke, Martin K Rutter, Mamas A Mamas. Diabetes Care 2015
208
33

Contrasting Effects of Lixisenatide and Liraglutide on Postprandial Glycemic Control, Gastric Emptying, and Safety Parameters in Patients With Type 2 Diabetes on Optimized Insulin Glargine With or Without Metformin: A Randomized, Open-Label Trial.
Juris J Meier, Julio Rosenstock, Agnès Hincelin-Méry, Christine Roy-Duval, Astrid Delfolie, Hans-Veit Coester, Bjoern A Menge, Thomas Forst, Christoph Kapitza. Diabetes Care 2015
156
33

Glycemic Variability Percentage: A Novel Method for Assessing Glycemic Variability from Continuous Glucose Monitor Data.
Thomas A Peyser, Andrew K Balo, Bruce A Buckingham, Irl B Hirsch, Arturo Garcia. Diabetes Technol Ther 2018
26
33

The Association of Severe Hypoglycemia With Incident Cardiovascular Events and Mortality in Adults With Type 2 Diabetes.
Alexandra K Lee, Bethany Warren, Clare J Lee, John W McEvoy, Kunihiro Matsushita, Elbert S Huang, A Richey Sharrett, Josef Coresh, Elizabeth Selvin. Diabetes Care 2018
65
33

Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
Roy W Beck, Tonya Riddlesworth, Katrina Ruedy, Andrew Ahmann, Richard Bergenstal, Stacie Haller, Craig Kollman, Davida Kruger, Janet B McGill, William Polonsky,[...]. JAMA 2017
381
33


Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2).
Bernard Zinman, Steven P Marso, Neil R Poulter, Scott S Emerson, Thomas R Pieber, Richard E Pratley, Martin Lange, Kirstine Brown-Frandsen, Alan Moses, Ann Marie Ocampo Francisco,[...]. Diabetologia 2018
74
33


The effect of glucose variability on the risk of microvascular complications in type 1 diabetes.
Eric S Kilpatrick, Alan S Rigby, Stephen L Atkin. Diabetes Care 2006
228
33

Glycaemic variability in diabetes: clinical and therapeutic implications.
Antonio Ceriello, Louis Monnier, David Owens. Lancet Diabetes Endocrinol 2019
122
33


Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range.
Tadej Battelino, Thomas Danne, Richard M Bergenstal, Stephanie A Amiel, Roy Beck, Torben Biester, Emanuele Bosi, Bruce A Buckingham, William T Cefalu, Kelly L Close,[...]. Diabetes Care 2019
542
33

GLP-1 analog liraglutide protects against oxidative stress and albuminuria in streptozotocin-induced diabetic rats via protein kinase A-mediated inhibition of renal NAD(P)H oxidases.
Hari Hendarto, Toyoshi Inoguchi, Yasutaka Maeda, Noriko Ikeda, Jing Zheng, Ryoko Takei, Hisashi Yokomizo, Eiichi Hirata, Noriyuki Sonoda, Ryoichi Takayanagi. Metabolism 2012
136
16


Relationship between daily and day-to-day glycemic variability and increased oxidative stress in type 2 diabetes.
Makoto Ohara, Tomoyasu Fukui, Motoshi Ouchi, Kentaro Watanabe, Tatsuya Suzuki, Saki Yamamoto, Takeshi Yamamoto, Toshiyuki Hayashi, Kenzo Oba, Tsutomu Hirano. Diabetes Res Clin Pract 2016
44
16

Inter-relationships between DNA damage, ascorbic acid and glycaemic control in Type 2 diabetes mellitus.
S W Choi, I F F Benzie, C S Y Lam, S W S Chat, J Lam, C H Yiu, J J Kwan, Y H Tang, G S P Yeung, V T F Yeung,[...]. Diabet Med 2005
29
16

The pleiotropic effects of statins.
Paolo Calabrò, Edward T H Yeh. Curr Opin Cardiol 2005
119
16

Oxidative stress and diabetic vascular complications.
D Giugliano, A Ceriello, G Paolisso. Diabetes Care 1996
16

Effect of repaglinide versus glimepiride on daily blood glucose variability and changes in blood inflammatory and oxidative stress markers.
Masahiro Yamazaki, Goji Hasegawa, Saori Majima, Kazuteru Mitsuhashi, Takuya Fukuda, Hiroya Iwase, Mayuko Kadono, Mai Asano, Takafumi Senmaru, Muhei Tanaka,[...]. Diabetol Metab Syndr 2014
22
16

Silent hemoglobin variants and determination of HbA(1c) with the high-resolution program of the HPLC HA-8160 hemoglobin analyzer.
Wolfgang J Schnedl, Theresa Lahousen, Sandra J Wallner, Robert Krause, Rainer W Lipp. Clin Biochem 2005
42
16

Simultaneous GLP-1 and insulin administration acutely enhances their vasodilatory, antiinflammatory, and antioxidant action in type 2 diabetes.
Antonio Ceriello, Anna Novials, Silvia Canivell, Lucia La Sala, Gemma Pujadas, Katherine Esposito, Roberto Testa, Loredana Bucciarelli, Maurizio Rondinelli, Stefano Genovese. Diabetes Care 2014
47
16

Effect of nateglinide on the incidence of diabetes and cardiovascular events.
Rury R Holman, Steven M Haffner, John J McMurray, M Angelyn Bethel, Björn Holzhauer, Tsushung A Hua, Yuri Belenkov, Mitradev Boolell, John B Buse, Brendan M Buckley,[...]. N Engl J Med 2010
299
16

Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan -2012 version.
Tamio Teramoto, Jun Sasaki, Shun Ishibashi, Sadatoshi Birou, Hiroyuki Daida, Seitaro Dohi, Genshi Egusa, Takafumi Hiro, Kazuhiko Hirobe, Mami Iida,[...]. J Atheroscler Thromb 2013
284
16

Glucagon-like peptide 1 reduces endothelial dysfunction, inflammation, and oxidative stress induced by both hyperglycemia and hypoglycemia in type 1 diabetes.
Antonio Ceriello, Anna Novials, Emilio Ortega, Silvia Canivell, Lucia La Sala, Gemma Pujadas, Katherine Esposito, Dario Giugliano, Stefano Genovese. Diabetes Care 2013
101
16

A simple test to monitor oxidative stress.
M R Cesarone, G Belcaro, M Carratelli, U Cornelli, M T De Sanctis, L Incandela, A Barsotti, R Terranova, A Nicolaides. Int Angiol 1999
323
16

Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A.
Hisko Oeseburg, Rudolf A de Boer, Hendrik Buikema, Pim van der Harst, Wiek H van Gilst, Herman H W Silljé. Arterioscler Thromb Vasc Biol 2010
174
16

Evidence that hyperglycemia after recovery from hypoglycemia worsens endothelial function and increases oxidative stress and inflammation in healthy control subjects and subjects with type 1 diabetes.
Antonio Ceriello, Anna Novials, Emilio Ortega, Lucia La Sala, Gemma Pujadas, Roberto Testa, Anna Rita Bonfigli, Katherine Esposito, Dario Giugliano. Diabetes 2012
90
16

Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial.
Jean-Louis Chiasson, Robert G Josse, Ramon Gomis, Markolf Hanefeld, Avraham Karasik, Markku Laakso. JAMA 2003
16



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.